Hattinger, C.M.; Salaroglio, I.C.; Fantoni, L.; Godel, M.; Casotti, C.; Kopecka, J.; Scotlandi, K.; Ibrahim, T.; Riganti, C.; Serra, M.
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. Int. J. Mol. Sci. 2023, 24, 799.
https://doi.org/10.3390/ijms24010799
AMA Style
Hattinger CM, Salaroglio IC, Fantoni L, Godel M, Casotti C, Kopecka J, Scotlandi K, Ibrahim T, Riganti C, Serra M.
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences. 2023; 24(1):799.
https://doi.org/10.3390/ijms24010799
Chicago/Turabian Style
Hattinger, Claudia Maria, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, and Massimo Serra.
2023. "Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma" International Journal of Molecular Sciences 24, no. 1: 799.
https://doi.org/10.3390/ijms24010799
APA Style
Hattinger, C. M., Salaroglio, I. C., Fantoni, L., Godel, M., Casotti, C., Kopecka, J., Scotlandi, K., Ibrahim, T., Riganti, C., & Serra, M.
(2023). Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences, 24(1), 799.
https://doi.org/10.3390/ijms24010799